Latest industry research report on: Immuno-Oncology Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts

Albany, NY -- (SBWire) -- 10/09/2017 --Immuno-Oncology (IO) is uniquely positioned to become the fifth pillar of cancer treatment alongside surgery, radiotherapy, chemotherapy, and other targeted treatments. In order to assist our clients with navigating the burgeoning amount information arising as a result of the rapidly growing field of IO clinical research, GlobalData is offering a comprehensive analysis of both pipeline and marketed active immunity IO therapies.

Scope

Key Topics Covered -
- Immune Checkpoint Modulators - Trends in Clinical Trial Development
- Competitive Assessment of Marketed PD-(L)1 Checkpoint Modulators
- Emergence of New Immune Checkpoint Targets
- Clinical and Commercial Opportunities for Highly Anticipated CAR Cell Therapies
- Cell Vaccines: Steady Development Stimulated by Prior IO Success
- Promising IO-IO Combinations Utilizing Oncolytic Viruses

Request For Sample Report @https://www.marketresearchreports.biz/sample/sample/1339303

Reasons to buy

- The PharmaFocus consists of a highly-visual slide deck that is intended to facilitate the dissemination of aggregated data and insights from analyses of over 800 IO products that are either marketed or in Phase I-III of clinical development.

- Types of graphical analyses include - Cumulative Plots, Aggregated Bubble Plots, Pie Charts, Matrix Analyses

- Unique, actionable insights applicable to IO drugs in five major categories: Immune Checkpoint Modulators, Cellular Immunotherapies, Oncolytic Viruses, Peptide Vaccines, and Bispecific T-Cell Engagers are provided in this report.

- Analysis of over 4000 clinical trials enrolling patients with 18 solid tumors and eight hematological cancers are included.

Have Any Query? Ask Our Expert @https://www.marketresearchreports.biz/sample/enquiryBuy/1339303

Table of Contents

1. Preface
1.1 Related Reports 4
1.2 Upcoming Reports 5
1.3 Abbreviations 6

2. Immuno-Oncology Product Definition and Classification 7

3. Recent Timeline of Immuno-Oncology Approvals 11

4. Immune Checkpoint Modulators - Trends in Clinical Trial Development 19
4.1 Clinical Trial Activity for Checkpoint Modulators Remains Essentially Driven by PD-(L)1 and CTLA-4 Targeting Agents 20-25
4.2 Academic Institutions Are Key Drivers for Early Stage Clinical Research, but Patient Recruitment is Highly Dependent on Companies 26-32
4.3 Geographic Locations of Trials Assessing Immune Checkpoint Modulators 33-37

5. Competitive Assessment of Marketed PD-(L)1 Checkpoint Modulators 38
5.1 Clinical Positioning of Marketed PD-(L)1 Inhibitors 39-45
5.2 Commercial Attributes of Marketed PD-(L)1 Checkpoint Modulators 46-56
5.3 Dynamic of Clinical Development for Marketed PD-(L)1 Checkpoint Modulators 57-61
5.4 Clinical Development Coverage of Marketed PD-(L)1 Checkpoint Modulators in Solid Tumors and Blood Cancers 62-71

6. Emergence of New Immune Checkpoint Targets 72
6.1 Emergence of New Checkpoint Targets in Clinical Development 73-79
6.2 Clinical Development Coverage of Emerging Targets in Solid Tumors and Blood Cancers - Matrix Analysis 80-89

7. Cellular Immunotherapies in Clinical Development 90
7.1 Clinical Development of Cellular Immunotherapies 91-98
7.2 Clinical Development of Cytotoxic Cellular Immunotherapies 99-110

8. Clinical and Commercial Opportunities for Highly Anticipated CAR Cell Therapies 111
8.1 Development of and Opportunities for CAR Cell Therapies 112-123
8.2 Development of CAR Cell Therapies in Blood Cancers 124-130
8.3 Development of CAR Cell Therapies in Solid Tumors 131-137
9. Cell Vaccines: Steady Development Stimulated by Prior IO Success 138
9.1 Trends in Clinical Development of Cancer Vaccines 139-152

About MarketResearchReports.biz
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact
Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz